SNS Financial Group’s CME Group CME Stock Holding History

SNS Financial Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,200	Closed	-$642K	–	202
2019 Q4	$642K	Buy	+3,200	New	+$656K	0.11%	113

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SNS Financial Group's CME Position: Q2 2025 in Review

SNS Financial Group sold out of CME Group (CME) in Q2 2025, closing a stake of 1,447 shares — an estimated $384K sold.

SNS Financial Group first reported a position in CME in Q1 2016 and held it in 37 quarters. The position peaked at $6.13M in Q1 2017. 1,662 funds tracked by Wall St. Rank hold CME as of Q2 2025.

SNS Financial Group reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
SNS Financial Group sold 1,447 CME Group shares in Q2 2025, an estimated $384K.
SNS Financial Group first reported a position in CME Group in Q1 2016 and held it in 37 quarters.
SNS Financial Group's CME Group position peaked at $6.13M in Q1 2017.
1,662 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on SNS Financial Group's 13F filing for Q2 2025, filed 6 Aug 2025.